Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
Jean Connors, Chief of Cancer Hematology at Dana-Farber Cancer Institute, shared Journal of Thrombosis and Haemostasis‘s post on LinkedIn:
“Truly wonderful to work with the dedicated team of Brigham and Women’s Hospital pharmacists Elizabeth Caudill, Ju Hee Kim, Dareen Kanaan, Katelyn Sylvester, Liriany Pimentel Rodriguez, Christine Kim as part our Hemostatic Antithrombotic Stewardship program, to address this important question: can patients with remote HIT be re-exposed to UFH?”
Journal of Thrombosis and Haemostasis shared a post on LinkedIn about a recent article by Elizabeth B. Caudill et al, adding:
“Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia
This single-center retrospective study followed 35 patients with prior heparin-induced thrombocytopenia who were re-exposed to heparin products. Only one (2.9 percent) developed recurrent HIT, with no associated thrombosis, bleeding, or in-hospital mortality. Median interval from HIT diagnosis to re-exposure was 8.1 years, suggesting re-exposure may be safe in remote HIT.”
Title: Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia
Authors: Elizabeth B. Caudill, Ju Hee Kim, Dareen M. Kanaan, Katelyn W. Sylvester, Liriany Y. Pimentel, Christine S. Kim, Jean M. Connors
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets
-
Sep 23, 2026, 03:27Abbie Newton: How Better Data Can Reduce Platelet Wastage
-
Sep 23, 2026, 03:01Suvro Sankha Datta: Rapid Blood Group Genotyping Using Gold Oligo Nanonet Assembly
-
Sep 23, 2026, 02:55Asghar Muhammad: Exploring New Ways to Expand Blood Transfusion Compatibility
-
Sep 23, 2026, 02:49Bianca Rocca: Personalized Cardiovascular Pharmacotherapy in the September 2026 EHJ Issue
-
Sep 23, 2026, 02:35Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?